A pilot clinical trial of oral sodium 4-phenylbutyrate (Buphenyl) in δF508-Homozygous cystic fibrosis patients: Partial restoration of nasal epithelial CFTR function
Dive into the research topics of 'A pilot clinical trial of oral sodium 4-phenylbutyrate (Buphenyl) in δF508-Homozygous cystic fibrosis patients: Partial restoration of nasal epithelial CFTR function'. Together they form a unique fingerprint.